Needles, Haystacks and Next-Generation Genetic Sequencing

Area of Science:

• Genetics
• Bioethics
• Medical Law

Background:

• Genetic testing is increasingly common, yielding complex results.
• Incidental or secondary findings can arise from genetic analyses for other purposes.
• The American College of Medical Genetics (ACMG) recommended reporting specific, serious, treatable, and potentially undetected secondary mutations.

Purpose of the Study:

• To analyze the scope of negligence liability for clinical laboratories regarding secondary findings.
• To determine if laboratories should be subject to tort liability for failing to disclose secondary findings.

Main Methods:

• Legal and ethical analysis of ACMG recommendations.
• Examination of negligence liability principles in the context of genetic testing.

Main Results:

• ACMG recommendations for reporting secondary findings have generated significant debate.
• Laboratories may have ethical or professional duties to share certain genetic information.
• The article argues against imposing tort liability on laboratories for non-disclosure of secondary findings.

Conclusions:

• While ethical obligations exist for sharing specific secondary genetic findings, legal recourse through tort liability is not supported.
• Distinguishing between ethical duties and legal liability is crucial for clinical laboratories.
• The focus should be on professional guidelines rather than litigation for non-disclosure of incidental genetic information.